Cannabis Use Among Cancer Patients During Active Treatment: Findings From a Study at an NCI‐Designated Cancer Center

ABSTRACT Objective This study aims to describe patterns, sources, and reasons for cannabis use among cancer patients during active treatment (+CDTX) compared to no‐use during active treatment (−CDTX). Methods Data are from 385 surveys collected via REDCap during phase I of an ongoing study among adu...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2024-11, Vol.13 (21), p.e70384-n/a
Main Authors: Baral, Amrit, Diggs, Bria‐Necole A., Marrakchi El Fellah, Ranya, McCarley, Connor, Penedo, Frank, Martinez, Claudia, Vidot, Denise C.
Format: Article
Language:English
Subjects:
Adult
Aged
Antiemetics
cancer
Cancer Care Facilities - statistics & numerical data
Cancer therapies
cancer treatment chemotherapy
Cannabinoids
Cannabis
CBD
Chemotherapy
Drug interaction
Ethnicity
Female
Humans
Immune system
Immunotherapy
Inhalation
Male
Marijuana
Medical diagnosis
Medical Marijuana - therapeutic use
Mental depression
Middle Aged
Mood
National Cancer Institute (U.S.)
Nausea
Neoplasms - drug therapy
Neoplasms - epidemiology
Neoplasms - therapy
Oncology
Pain management
Patients
Quality of life
radiation
Radiation therapy
Self report
Side effects
Sociodemographics
Statistical analysis
Surgery
Surveys
Surveys and Questionnaires
Symptom management
Tetrahydrocannabinol
THC
United States - epidemiology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Objective This study aims to describe patterns, sources, and reasons for cannabis use among cancer patients during active treatment (+CDTX) compared to no‐use during active treatment (−CDTX). Methods Data are from 385 surveys collected via REDCap during phase I of an ongoing study among adult cancer patients seen at an NCI‐designated comprehensive cancer center within the last 5 years of treatment. A harmonized survey was created with 11 other NCI centers to assess cannabis use patterns, sources, and reasons for use. Sociodemographics and cancer details were also collected via self‐report. Descriptive statistics were calculated and stratified by +/−CDTX. Chi‐squared tests were conducted to compare proportions between groups. Results Among the sample [49.5 years (SD 15.9); 53.0% male; and 41.6% Hispanic/Latino], 41.0% + CDTX and 59.0% −CDTX. A majority (71.8%) of +CDTX initiated use before diagnosis versus 44.1% in −CDTX (p 
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.70384